Skip to content
AIPressRoom

FundingHealthcare & Biotech

Treat Raises €3M to Scale AI Primary Care

Treat raised €3M Pre-seed led by byFounders and Illusian to scale its AI-powered primary care platform across Europe.

Sami Marttinen, Co-founder of Treat

The big picture: Treat, a Helsinki-based AI healthtech company, has raised €3 million in pre-seed funding. The round was led by byFounders and Illusian, the latter founded by Supercell’s Ilkka Paananen. The platform aims to streamline primary care by connecting patients with doctors who have pre-reviewed their medical history, leveraging AI to gather necessary information efficiently.

Why it matters:

  • Fragmented Care: Treat addresses the inefficiencies in private healthcare, where patients often undergo multiple repeat visits due to fragmented systems and a lack of incentive for doctors to consolidate existing medical records.
  • Patient-Centric Model: The company’s model aligns incentives with patient resolution, making zero revenue from lab tests, clinic visits, or referrals. Its sole focus is on solving the patient’s issue on the first visit.
  • AI for Efficiency: By using AI to gather symptoms and check insurance coverage, Treat aims to reduce administrative burden and ensure doctors have comprehensive information before consultations, leading to faster diagnoses and resolutions.

How it works:

  • AI-Guided Symptom Intake: Patients describe their symptoms via text or voice, and Treat’s AI asks follow-up questions to collect the specific information a doctor needs for an informed review.
  • Pre-Consultation Review: Doctors review a patient’s full medical history and the AI-generated summary before the consultation, eliminating the need for patients to repeat their story at each visit.
  • Integrated Coverage Checks: The system automatically verifies insurance and employer coverage, simplifying the process for patients and guiding them to the appropriate level of care without unnecessary steps.

The catch: Treat enters a highly competitive Nordic AI health sector, with established players like Gosta Labs in oncology, Oura’s acquisition of Counsel Health for AI-native primary care, and Tandem Health’s $100 million raise for an AI clinic OS. While Treat claims no direct competitors, its indirect competition from occupational healthcare and insurance providers is significant. The success of its ‘no-referral’ model at scale, particularly as it aims for expansion into over five countries, will depend on its ability to integrate seamlessly with existing healthcare contracts and demonstrate consistent, high-quality patient outcomes.

Key Facts

  • Company: Treat
  • Amount: €3M
  • Round: Pre-Seed
  • Investor: byFounders and Illusian (co-lead)
  • Founders: Sami Marttinen, Antti Mauno, Onni Wahlberg
  • Sector: AI Primary Care
  • Headquarters: Helsinki, Finland

AIPressRoom Weekly

Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.

More in Healthcare & Biotech

All